Dr. Swaran Lata Batra , MD
Internal Medicine • Lubbock, TX
9812 Slide Rd
Lubbock, TX 794245781
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Swaran Batra is listed in NPPES under Internal Medicine.
-
NPI assigned on April 11, 2006; this date does not establish years in practice.
-
Published CMS data list 2,314 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 407 service units.
- J2919 — Injection, methylprednisolone sodium succinate, 5 mg: 252 service units.
- 36415 — Insertion of needle into vein for collection of blood sample: 234 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 30 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 4,520 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium — 209 prescription fills, including refills.
- Levothyroxine Sodium — 200 prescription fills, including refills.
- Metformin Hcl — 190 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 95 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 80% of clinicians listed under Internal Medicine in Lubbock, TX (2024, 72 clinicians with data). Median for this group: 657. Middle half: 280 to 1,399.
More Medicare Part B services than 85% of clinicians listed under Internal Medicine in Texas (2024, 5,420 clinicians with data). Median for this group: 644. Middle half: 277 to 1,324.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,345 in 2020 to 2,314 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
9812 Slide Rd
Lubbock, TX 794245781
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
209 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $98,443 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $75,505 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
10,649 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$355,106 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $275.72 across 13 records.
By nature of payment
- Food and Beverage: $275.72 across 13 records.
Reporting-company totals (3 largest of 6)
- Novo Nordisk Inc: $67.82 across 3 records.
- Eli Lilly and Company: $57.28 across 3 records.
- ABBVIE INC.: $52.69 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Compared with the same specialty in Lubbock and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 80% of clinicians listed under Internal Medicine in Lubbock, TX (2024, 72 clinicians with data). Median for this group: 657. Middle half: 280 to 1,399.
More Medicare Part B services than 85% of clinicians listed under Internal Medicine in Texas (2024, 5,420 clinicians with data). Median for this group: 644. Middle half: 277 to 1,324.
Medicare-allowed amount
A higher Medicare-allowed amount than 60% of clinicians listed under Internal Medicine in Lubbock, TX (2024, 72 clinicians with data). Median for this group: $64,054. Middle half: $23,731 to $131,730.
A higher Medicare-allowed amount than 65% of clinicians listed under Internal Medicine in Texas (2024, 5,420 clinicians with data). Median for this group: $61,173. Middle half: $27,477 to $116,014.
Paid by Medicare
A higher Medicare payment amount than 60% of clinicians listed under Internal Medicine in Lubbock, TX (2024, 72 clinicians with data). Median for this group: $49,663. Middle half: $18,894 to $103,597.
A higher Medicare payment amount than 65% of clinicians listed under Internal Medicine in Texas (2024, 5,420 clinicians with data). Median for this group: $47,441. Middle half: $20,511 to $90,151.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Internal Medicine in Lubbock, TX (2024, 85 clinicians with data). Median for this group: 319. Middle half: 106 to 2,408.
More Part D prescriptions than 70% of clinicians listed under Internal Medicine in Texas (2024, 5,692 clinicians with data). Median for this group: 815. Middle half: 119 to 4,814.
Part D drug cost
A higher Part D drug cost than 75% of clinicians listed under Internal Medicine in Lubbock, TX (2024, 85 clinicians with data). Median for this group: $38,050. Middle half: $7,684 to $332,818.
A higher Part D drug cost than 70% of clinicians listed under Internal Medicine in Texas (2024, 5,692 clinicians with data). Median for this group: $62,823. Middle half: $3,924 to $436,115.
119 active clinicians are listed under Internal Medicine with a practice address in Lubbock, TX (9,244 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Lubbock
5% of these 119 clinicians have the CMS telehealth indicator.
64.7% of these 119 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 31% from 3,345 in 2020 to 2,314 in 2024.
- 2020: 3,345
- 2021: 3,270
- 2022: 2,586
- 2023: 2,295
- 2024: 2,314
-
Medicare-allowed amount
Medicare-allowed amount decreased 22% from $125,703 in 2020 to $98,443 in 2024.
- 2020: $125,703
- 2021: $134,338
- 2022: $116,804
- 2023: $106,272
- 2024: $98,443
-
Paid by Medicare
Paid by Medicare decreased 17% from $90,927 in 2020 to $75,505 in 2024.
- 2020: $90,927
- 2021: $100,420
- 2022: $90,673
- 2023: $80,149
- 2024: $75,505
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 16% from 5,367 in 2020 to 4,520 in 2024.
- 2020: 5,367
- 2021: 5,009
- 2022: 4,535
- 2023: 4,472
- 2024: 4,520
-
30-day fills
30-day fills stayed about the same: 11,687 in 2020 and 10,649 in 2024.
- 2020: 11,687
- 2021: 11,657
- 2022: 10,296
- 2023: 10,434
- 2024: 10,649
-
Part D drug cost
Part D drug cost decreased 13% from $408,559 in 2020 to $355,106 in 2024.
- 2020: $408,559
- 2021: $359,694
- 2022: $315,913
- 2023: $380,890
- 2024: $355,106
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 73% from $1,028.21 in 2021 to $275.72 in 2025.
- 2021: $1,028.21
- 2022: $568.09
- 2023: $526.71
- 2024: $548.55
- 2025: $275.72
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 13 records totaling $275.72.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $33.54 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Rybelsus | General | $28.28 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $23.64 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $23.41 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $22.91 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $20.23 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
UBRELVY | General | $19.27 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $19.04 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $18.07 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $18.01 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
UBRELVY | General | $17.35 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $16.07 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $15.90 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
407 | 169 | $177.00 | $122.36 |
|
J2919
Injection, methylprednisolone sodium succinate, 5 mg
|
252 | 12 | $2.00 | $0.28 |
|
36415
Insertion of needle into vein for collection of blood sample
|
234 | 122 | $18.00 | $8.65 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
174 | 100 | $125.00 | $86.78 |
|
80053
Blood test, comprehensive group of blood chemicals
|
159 | 104 | $45.00 | $10.35 |
|
85025
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
|
117 | 89 | $32.00 | $7.61 |
|
84443
Blood test, thyroid stimulating hormone (tsh)
|
110 | 76 | $71.00 | $16.46 |
|
80061
Blood test, lipids (cholesterol and triglycerides)
|
106 | 75 | $93.00 | $13.12 |
|
83036
Hemoglobin a1c level
|
100 | 49 | $40.00 | $9.52 |
|
G0439
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
|
86 | 86 | $341.00 | $123.65 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
68 | 15 | $10.00 | $0.95 |
|
96372
Injection of drug or substance under skin or into muscle
|
66 | 51 | $63.00 | $13.60 |
|
87635
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen
|
41 | 39 | $160.00 | $50.28 |
|
G0008
Administration of influenza virus vaccine
|
41 | 41 | $90.33 | $31.03 |
|
90653
Influenza vaccine, inactivated
|
38 | 38 | $70.00 | $68.60 |
|
81002
Urinalysis, manual test
|
29 | 20 | $11.00 | $3.41 |
|
87651
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
|
29 | 29 | $100.00 | $34.39 |
|
82306
Vitamin d-3 level
|
27 | 21 | $124.00 | $29.01 |
|
82607
Cyanocobalamin (vitamin b-12) level
|
27 | 22 | $63.00 | $14.78 |
|
81001
Manual urinalysis test with examination using microscope, automated
|
24 | 20 | $13.00 | $3.11 |
|
82043
Urine microalbumin (protein) level
|
23 | 18 | $25.00 | $5.66 |
|
82570
Creatinine level to test for kidney function or muscle injury
|
22 | 18 | $21.00 | $5.08 |
|
71046
X-ray of chest, 2 views
|
19 | 17 | $102.00 | $21.69 |
|
85652
Red blood cell sedimentation rate, to detect inflammation, automated
|
19 | 15 | $11.00 | $2.65 |
|
G0103
Prostate cancer screening; prostate specific antigen test (psa)
|
19 | 19 | $81.00 | $18.92 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 209 | 18,187 | $1,566.62 | 68 |
| Levothyroxine Sodium | Levothyroxine Sodium | 200 | 15,995 | $2,175.83 | 57 |
| Metformin Hcl | Metformin Hcl | 190 | 16,260 | $1,173.97 | 61 |
| Amlodipine Besylate | Amlodipine Besylate | 179 | 15,215 | $1,215.93 | 62 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 162 | 13,100 | $2,337.46 | 50 |
| Losartan Potassium | Losartan Potassium | 155 | 12,673 | $1,246.67 | 49 |
| Lisinopril | Lisinopril | 154 | 12,973 | $1,198.11 | 42 |
| Metoprolol Succinate | Metoprolol Succinate | 132 | 10,408 | $1,480.15 | 42 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 127 | 11,100 | $1,481.65 | 46 |
| Gabapentin | Gabapentin | 124 | 9,805 | $2,140.82 | 45 |
| Omeprazole | Omeprazole | 118 | 9,730 | $1,834.38 | 42 |
| Tramadol Hcl | Tramadol Hcl | 112 | 3,407 | $941.39 | 30 |
| Pantoprazole Sodium | Pantoprazole Sodium | 109 | 8,820 | $738.13 | 35 |
| Mounjaro | Tirzepatide | 101 | 3,120 | $113,195.63 | 14 |
| Azithromycin | Azithromycin | 96 | 524 | $452.44 | 90 |
| Montelukast Sodium | Montelukast Sodium | 94 | 7,860 | $972.27 | 34 |
| Allopurinol | Allopurinol | 85 | 7,170 | $722.65 | 27 |
| Furosemide | Furosemide | 80 | 5,685 | $380.84 | 27 |
| Potassium Chloride | Potassium Chloride | 76 | 5,985 | $1,453.16 | 28 |
| Glipizide | Glipizide | 72 | 6,390 | $778.60 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 63 | 5,370 | $691.38 | 19 |
| Ibandronate Sodium | Ibandronate Sodium | 57 | 5,040 | $2,074.36 | 24 |
| Simvastatin | Simvastatin | 56 | 4,860 | $279.23 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 56 | 2,555 | $1,145.25 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 55 | 1,583 | $1,382.46 | 21 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Family Medicine
Doctor of Medicine (M.D.)
Internal Medicine - Cardiovascular Disease
Doctor of Medicine (M.D.)
Family Medicine
Doctor of Osteopathic Medicine (D.O.)
Internal Medicine
Doctor of Osteopathic Medicine (D.O.)
Internal Medicine
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Family Nurse Practitioner
Career & Practice History
NPI enumerated April 11, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Internal Medicine Providers in Lubbock
- Dr. Kandis Boothe, MD, PhD
- Kishore Karri
- Dr. Neha Mittal, MD
- Dr. Robert Bisbee, MD
- Dr. Roshni Narayanan, MD
- Dr. Dolores Buscemi, MD
Mailing Address
3420 22nd Pl
Lubbock, TX 794101314
Phone: 8067257800